MQS Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$417K Sell
5,335
-4,401
-45% -$355K 0.51% 51
2026
Q1
$844K Buy
9,736
+2,880
+42% +$276K 0.57% 18
2025
Q4
$659K Buy
+6,856
New +$666K 0.39% 69
2025
Q2
Sell
-7,715
Closed -$693K 581
2025
Q1
$693K Buy
+7,715
New +$690K 0.4% 54
2024
Q3
Sell
-9,363
Closed -$737K 569
2024
Q2
$737K Buy
9,363
+3,587
+62% +$294K 0.45% 36
2024
Q1
$503K Buy
+5,776
New +$493K 0.29% 118
2022
Q4
Sell
-8,305
Closed -$671K 503
2022
Q3
$671K Buy
+8,305
New +$746K 0.43% 49
2022
Q1
Sell
-4,404
Closed -$456K 388
2021
Q4
$456K Buy
+4,404
New +$510K 0.73% 34

Other funds holding MDT

MQS Management's MDT Position: Q2 2026 in Review

MQS Management reduced its Medtronic (MDT) stake by 45% in Q2 2026, selling an estimated $355K and leaving 5,335 shares worth $417K. The position accounts for 0.51% of the portfolio, ranked #51.

MQS Management first reported a position in MDT in Q4 2021 and has held it in 8 quarters since. The position peaked at $844K in Q1 2026. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • MQS Management held 5,335 shares of Medtronic worth $417K as of Q2 2026.
  • MQS Management sold 4,401 Medtronic shares in Q2 2026, an estimated $355K.
  • Medtronic made up 0.51% of MQS Management's portfolio in Q2 2026, its #51 holding.
  • MQS Management first reported a position in Medtronic in Q4 2021 and has held it in 8 quarters since.
  • MQS Management's Medtronic position peaked at $844K in Q1 2026.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.